Osimertinib (Tagrisso) and Melatonin

Author:

Richard I. Shader
Richard I. Shader

Publisher website

25 November 2023

journal article
letter
Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology

Vol. 44 (1) , 72-73
DOI:10.1097/jcp.0000000000001775
PMID:38011040

Abstract

No abstract available

Keywords

This publication has 6 references indexed in Scilit:

Overall Survival with Osimertinib in Resected EGFR -Mutated NSCLC
New England Journal of Medicine, 2023
Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US
2023
Comparison of potential psychiatric drug interactions in six drug interaction database programs: A replication study after 2 years of updates
Human Psychopharmacology: Clinical and Experimental, 2021
Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content
Journal of Clinical Sleep Medicine, 2017
Human Phase Response Curves to Three Days of Daily Melatonin: 0.5 mgVersus3.0 mg
The Journal of Clinical Endocrinology & Metabolism, 2010
METABOLISM OF MELATONIN BY HUMAN CYTOCHROMES P450
Drug Metabolism and Disposition, 2005